To Evaluate the Efficacy, Safety and Population Pharmacokinetics of GST-HG141 in Patients With Chronic Hepatitis B (CHB) Who Have an Inadequate Response to Antiviral Drug Treatment
Clinical trial NCT07090759 · RECRUITING
Trial details
- NCT number
- NCT07090759
- Sponsor
- Fujian Akeylink Biotechnology Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-24
- Primary completion
- 2026-12-01
- Enrollment
- 526
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.